Clarithromycin-Associated Acute Liver Failure Leading to Fatal, Massive Upper Gastrointestinal Hemorrhage from Profound Coagulopathy: Case Report and Systematic Literature Review

Joint Authors

Cappell, Mitchell S.
Shams, Christienne
Amin, Mitual
Edhi, Ahmed
Hakim, Seifeldin
Bedi, Damanpreet

Source

Case Reports in Hepatology

Issue

Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-7, 7 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2020-02-18

Country of Publication

Egypt

No. of Pages

7

Main Subjects

Diseases

Abstract EN

While erythromycin has caused numerous cases of acute liver failure (ALF), clarithromycin, a similar macrolide antibiotic, has caused only six reported cases of ALF.

A new case of clarithromycin-associated ALF is reported with hepatic histopathology and exclusion of other etiologies by extensive workup, and the syndrome of clarithromycin-associated ALF is better characterized by systematic review.

A 60-year-old nonalcoholic man, with normal baseline liver function tests, was admitted with diffuse abdominal pain and AST = 499 U/L and ALT = 539 U/L, six days after completing a 7-day course of clarithromycin 500 mg twice daily for suspected upper respiratory infection.

AST and ALT each rose to about 1,000 U/L on day-2 of admission, and rose to ≥6,000 U/L on day-3, with development of severe hepatic encephalopathy and severe coagulopathy.

Planned liver biopsy was cancelled due to coagulopathies.

Extensive evaluation for infectious, immunologic, and metabolic causes of liver disease was negative.

Abdominal computerized tomography and abdominal ultrasound with Doppler were unremarkable.

The patient developed massive, acute upper gastrointestinal bleeding associated with coagulopathies.

Esophagogastroduodenoscopy was planned after massive blood product transfusions, but the patient rapidly expired from hemorrhagic shock.

Autopsy revealed a golden-brown heavy liver with massive hepatic necrosis and sinusoidal congestion.

Rise of AST/ALT to about 1,000 U/L each was temporally incompatible with shock liver because this rise preceded the hemorrhagic shock, but the subsequent AST/ALT rise to ≥6,000 U/L each may have had a component of shock liver.

The six previously reported cases were limited by failure to exclude hepatitis E (4), lack of liver biopsy (2), and uninterpretable liver biopsy (1) and by confounding potential etiologies including disulfiram, israpidine, or recent acetaminophen use (3), clarithromycin overdose (1), active alcohol use (1), and severe heart failure (1).

Review of 6 previously reported and current case of clarithromycin-associated ALF revealed that patients had AST and ALT values in the thousands.

Five patients died and 2 survived.

American Psychological Association (APA)

Edhi, Ahmed& Hakim, Seifeldin& Shams, Christienne& Bedi, Damanpreet& Amin, Mitual& Cappell, Mitchell S.. 2020. Clarithromycin-Associated Acute Liver Failure Leading to Fatal, Massive Upper Gastrointestinal Hemorrhage from Profound Coagulopathy: Case Report and Systematic Literature Review. Case Reports in Hepatology،Vol. 2020, no. 2020, pp.1-7.
https://search.emarefa.net/detail/BIM-1147920

Modern Language Association (MLA)

Edhi, Ahmed…[et al.]. Clarithromycin-Associated Acute Liver Failure Leading to Fatal, Massive Upper Gastrointestinal Hemorrhage from Profound Coagulopathy: Case Report and Systematic Literature Review. Case Reports in Hepatology No. 2020 (2020), pp.1-7.
https://search.emarefa.net/detail/BIM-1147920

American Medical Association (AMA)

Edhi, Ahmed& Hakim, Seifeldin& Shams, Christienne& Bedi, Damanpreet& Amin, Mitual& Cappell, Mitchell S.. Clarithromycin-Associated Acute Liver Failure Leading to Fatal, Massive Upper Gastrointestinal Hemorrhage from Profound Coagulopathy: Case Report and Systematic Literature Review. Case Reports in Hepatology. 2020. Vol. 2020, no. 2020, pp.1-7.
https://search.emarefa.net/detail/BIM-1147920

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1147920